Search

everythinglearnresearchcommunity

for

Search:↓

Most patients with frontal fibrosing alopecia are postmenopausal women, and treatments like finasteride and dutasteride can improve or stabilize the condition.

Lichen Planus is a less common condition affecting skin and mucous membranes, with various types and associated risk factors, challenging to diagnose, significantly impacts life quality, and may have a risk of cancerous changes in oral lesions.

The study found that Frontal Fibrosing Alopecia affects a broader age range of women and early treatment can help stop hair loss.

Decreased CD200 in hair follicles may cause immune issues in some alopecia areata cases.

Postmenopausal women can experience hairline recession, affecting their quality of life, and more research is needed for treatments.

Antimalarial agents are effective for LPP, and intralesional steroids are effective for FFA.

Hair follicles are complex, dynamic mini-organs that help us understand cell growth, death, migration, and differentiation, as well as tissue regeneration and tumor biology.

Future hair loss treatments should aim to extend hair growth, reactivate resting follicles, reverse shrinkage, and possibly create new follicles, with gene therapy showing promise.

AGA causes hair loss by shrinking hair follicles due to DHT binding, and can be treated with finasteride and minoxidil.

Hair ages due to genetics and environmental factors, leading to graying and thinning, with treatments available for some conditions.

Hair follicle stem cells are a promising source for tissue repair and treating skin or hair diseases.

Sunlight worsens hair loss; protect scalp.

Endocrine therapies for cancer significantly increase the risk of hair loss.

The dietary supplement helped increase hair growth in women with hair loss.

Hormones and neuroendocrine factors control hair growth and color, and more research could lead to new hair treatment options.

The current understanding of frontal fibrosing alopecia involves immune, genetic, hormonal factors, and possibly environmental triggers, but more research is needed for effective treatments.

Certain immune cells contribute to severe hair loss in chronic alopecia areata, with Th17 cells possibly having a bigger impact than cytotoxic T cells.

Male pattern baldness may be caused by scalp pressure on hair follicles, which increases with age and leads to a cycle of hair loss. This process is not directly determined by genes.

A substance called Vascular Endothelial Growth Factor can protect certain hair follicle stem cells from damage caused by androgens, suggesting a new possible treatment for hair loss.

Trichodynia is a painful scalp condition not directly linked to the amount or type of hair loss and may involve psychological factors, with treatments showing mixed results.

Trichoscopy helps diagnose hairline recession causes in Egyptian women, with androgenetic alopecia being the most common.

Hair follicle stem cells could be used to treat the skin condition vitiligo.

The document concludes that more research is needed to understand hair loss in men and to find new treatments.

Hair health depends on various factors and hair loss can significantly affect a person's well-being; understanding hair biology is key for creating effective hair care treatments.

Two trichoscopic patterns found in hair loss: diffuse fibrotic and androgenetic alopecia, affecting treatment choice and regrowth chances.

The document concludes that scalp cooling and treatments like minoxidil can help manage hair loss from cancer therapy.

The meeting showcased rare skin disease cases, highlighting the need for accurate diagnosis and treatment.

Lichen planopilaris and frontal fibrosing alopecia are likely the same disease with different clinical appearances.

Older adults often have skin problems due to aging, and treating these conditions requires attention to both physical and mental health.

Different types of persistent hair loss after chemotherapy respond differently to treatments.